Late Results of Cox Maze III Procedure in Patients with Atrial Fibrillation Associated with Structural Heart Disease

Gustavo Gir Gomes1,2, Wagner Luis Gali1,2, Alvaro Valentim Lima Sarabanda1,2

  • 1Instituto de Cardiologia do Distrito Federal - Fundação Universitária de Cardiologia (FUC), Brasília, DF - Brazil.

Insights

The Cox-Maze III procedure effectively restores sinus rhythm in atrial fibrillation (AF) patients, demonstrating excellent long-term survival and low stroke rates.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Electrophysiology
  • Atrial Fibrillation Management

Background:

  • The Cox-Maze III procedure is a surgical technique for treating atrial fibrillation (AF).
  • This study evaluates the long-term efficacy and safety of the Cox-Maze III procedure.

Purpose of the Study:

  • To assess the late results of the Cox-Maze III procedure regarding sinus rhythm maintenance.
  • To determine mortality and stroke rates after the Cox-Maze III procedure.

Main Methods:

  • Ninety-three patients underwent the Cox-Maze III procedure combined with structural heart disease repair between 2006 and 2013.
  • Heart rhythm was monitored using 24-hour Holter monitoring; recurrence predictors were analyzed using multivariate Cox regression.

Main Results:

  • Eighty patients with a mean follow-up of 27.5 months showed sinus rhythm maintenance rates of 88% at 6 months, 85.1% at 24 months, and 80.6% at 36 months.
  • Predictors for AF recurrence included female gender, coronary artery disease, and larger left atrium diameter.
  • Actuarial survival was 98.5%, and freedom from stroke was 97.5% at 48 months.

Conclusions:

  • The Cox-Maze III procedure is effective in maintaining sinus rhythm for patients with atrial fibrillation.
  • The procedure is associated with very low long-term mortality and stroke rates.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
334
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
344
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
365
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
877